Emergent BioSolutions Inc. financial data

Symbol
EBS on NYSE
Location
300 Professional Dr, Gaithersburg, MD
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Oct 30, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 523 % +316%
Quick Ratio 246 % +302%
Debt-to-equity 164 % -17.7%
Return On Assets 5.33 %
Operating Margin -10.4 % +85%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 52.5M shares -3.07%
Common Stock, Shares, Outstanding 52.7M shares -2.59%
Entity Public Float 361M USD -5.25%
Common Stock, Value, Issued 100K USD 0%
Weighted Average Number of Shares Outstanding, Basic 53.2M shares +0.19%
Weighted Average Number of Shares Outstanding, Diluted 56.5M shares +1.62%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.04B USD -0.54%
Revenue from Contract with Customer, Excluding Assessed Tax 231M USD -21.3%
Research and Development Expense 50.2M USD -44.8%
Operating Income (Loss) 119M USD +18.6%
Nonoperating Income (Expense) -12.6M USD +53%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 106M USD -59.6%
Income Tax Expense (Benefit) 30M USD -23.1%
Net Income (Loss) Attributable to Parent 75.9M USD -55.4%
Earnings Per Share, Basic 1 USD/shares -55.6%
Earnings Per Share, Diluted 1 USD/shares -55.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 246M USD +63.8%
Accounts Receivable, after Allowance for Credit Loss, Current 150M USD +23.2%
Inventory, Net 356M USD +10.4%
Assets, Current 787M USD +19%
Property, Plant and Equipment, Net 210M USD -24.6%
Operating Lease, Right-of-Use Asset 7.2M USD -41.9%
Intangible Assets, Net (Excluding Goodwill) 453M USD -12.6%
Goodwill 0 USD
Other Assets, Noncurrent 11.6M USD -43.4%
Assets 1.46B USD -1.14%
Accounts Payable, Current 57.4M USD -30.1%
Employee-related Liabilities, Current 36.6M USD -42.2%
Accrued Liabilities, Current 13.9M USD -13.7%
Contract with Customer, Liability, Current 6.1M USD -16.4%
Liabilities, Current 137M USD -40.6%
Deferred Income Tax Liabilities, Net 36.3M USD -13.4%
Operating Lease, Liability, Noncurrent 6.1M USD -43%
Other Liabilities, Noncurrent 42.6M USD +19%
Liabilities 879M USD -9.38%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.5M USD -2.74%
Retained Earnings (Accumulated Deficit) -105M USD +41.9%
Stockholders' Equity Attributable to Parent 583M USD +14.6%
Liabilities and Equity 1.46B USD -1.14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.2M USD +82.1%
Net Cash Provided by (Used in) Financing Activities -400K USD -101%
Net Cash Provided by (Used in) Investing Activities 59.5M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 60.6M shares +1.51%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 47.2M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 249M USD +59.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 16.7M USD -22.3%
Deferred Tax Assets, Valuation Allowance 339M USD +31.5%
Deferred Tax Assets, Gross 346M USD +28.5%
Operating Lease, Liability 7.9M USD -41%
Depreciation 33.2M USD -30%
Payments to Acquire Property, Plant, and Equipment 3.6M USD -66.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 75.7M USD -54.2%
Lessee, Operating Lease, Liability, to be Paid 15.3M USD -25%
Property, Plant and Equipment, Gross 501M USD -25.5%
Operating Lease, Liability, Current 1.8M USD -33.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.8M USD -24.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.6M USD -16.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +54.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.9M USD -6.45%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.2M USD -24.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares 0%
Unrecognized Tax Benefits 1.7M USD -74.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.8M USD -21.7%
Additional Paid in Capital 939M USD +1.54%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 65.1M USD +0.15%
Depreciation, Depletion and Amortization 25.4M USD -8.96%
Deferred Tax Assets, Net of Valuation Allowance 7.2M USD -38.5%
Share-based Payment Arrangement, Expense 15.2M USD -14.1%
Interest Expense 94.3M USD +101%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%